Prostate News Archive
17-Apr-2008
Fewer Prostate Cancer Deaths In The USA Than In The UK May Be Due To Screening (Medical News Today)
An article published in The Lancet Oncologysuggests that a higher incidence of screening for prostate-specificantingens in the USA is associated with a large decrease inprostate-cancer mortality in the USA compared to the UK between 1994and 2004. US prostate cancer deaths falling (Channel 4)
prostate cancer death rates have fallen almost four times faster in the US than in the UK since the early 1990s, a study has shown. The reason could be due to different approaches to screening and treatment in the two countries, say researchers. A Mixed Set Of Results From 5-Alpha-Reductase Inhibitors And Reduced Prostate Cancer Risk (Medical News Today)
Compared to placebo treatment, taking 5-alpha-reductase inhibitors (5-ARIs) can reduce a man's risk of being diagnosed with prostate cancer from around 5-9% to around 4-6% during up to 7 years of treatment, according to a new Cochrane Review. However, those who are diagnosed with prostate cancer may be at a slightly increased risk of having a more dangerous (high grade) tumour. Picking up the pieces on prostate cancer guideline (Scoop.co.nz)
The news that the Cancer Society will be taking a major role in the development of prostate cancer guidelines comes as a huge relief, says National?s Associate Health spokeswoman Jackie Blue. 'Jury out' on prostate screening (BBC News)
US death rates from prostate cancer have fallen, but that does not prove screening is effective, a study argues.
Back to Prostate News Archive
